Literature DB >> 15951974

Measurement of psychological factors associated with genetic testing for hereditary breast, ovarian and colon cancers.

Susan T Vadaparampil1, Mary Ropka, Michael E Stefanek.   

Abstract

Despite numerous individual studies of psychological factors (depression, anxiety, distress) related to genetic testing for inherited cancer syndromes (CGT), there has been no systematic review of the psychological factors are measured among individuals at increased risk for hereditary breast, ovarian, or colon cancer. Our review provides an analysis of psychological factors in studies of CGT and discusses the instruments most commonly used to measure them. We performed a literature search using three major OVID databases from 1993 to January 2003. In the 19 studies that met our inclusion criteria, the most commonly assessed psychological factors were distress, anxiety, and depression. These factors were most often measured by the impact of event scale (IES), the state-trait anxiety inventory (STAI), and the Centers for Epidemiologic Studies and Depression scale (CES-D), respectively. Our results show deficits in the existing body of literature on psychological factors associated with CGT including limited documentation of psychometrics and variability in instrumentation.

Entities:  

Mesh:

Year:  2005        PMID: 15951974     DOI: 10.1007/s10689-004-1446-7

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  53 in total

Review 1.  Psychosocial issues in cancer genetics: from the laboratory to the public.

Authors:  D J Bowen; A F Patenaude; S W Vernon
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-04       Impact factor: 4.254

Review 2.  Genetic testing for breast and ovarian cancer risk: the psychosocial issues.

Authors:  Jeannie V Pasacreta; Linda Jacobs; Janine K Cataldo
Journal:  Am J Nurs       Date:  2002-12       Impact factor: 2.220

Review 3.  Predictive genetic testing: psychological factors.

Authors:  P M Salkovskis; K A Rimes
Journal:  J Psychosom Res       Date:  1997-11       Impact factor: 3.006

4.  The State-Trait Anxiety Inventory: a systematic evaluation.

Authors:  P C Kendall; A J Finch; S M Auerbach; J F Hooke; P J Mikulka
Journal:  J Consult Clin Psychol       Date:  1976-06

5.  Effects of coping style and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk.

Authors:  K P Tercyak; C Lerman; B N Peshkin; C Hughes; D Main; C Isaacs; M D Schwartz
Journal:  Health Psychol       Date:  2001-05       Impact factor: 4.267

6.  Psychometric properties of the Impact of Event Scale amongst women at increased risk for hereditary breast cancer.

Authors:  B Thewes; B Meiser; I B Hickie
Journal:  Psychooncology       Date:  2001 Nov-Dec       Impact factor: 3.894

7.  A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire.

Authors:  David Cella; Chanita Hughes; Amy Peterman; Chih-Hung Chang; Beth N Peshkin; Marc D Schwartz; Lari Wenzel; Amy Lemke; Alfred C Marcus; Caryn Lerman
Journal:  Health Psychol       Date:  2002-11       Impact factor: 4.267

8.  Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample.

Authors:  Marc D Schwartz; Beth N Peshkin; Chanita Hughes; David Main; Claudine Isaacs; Caryn Lerman
Journal:  J Clin Oncol       Date:  2002-01-15       Impact factor: 44.544

Review 9.  Distress in individuals facing predictive DNA testing for autosomal dominant late-onset disorders: comparing questionnaire results with in-depth interviews. Rotterdam/Leiden Genetics Workgroup.

Authors:  A C DudokdeWit; A Tibben; H J Duivenvoorden; M F Niermeijer; J Passchier; R W Trijsburg
Journal:  Am J Med Genet       Date:  1998-01-06

10.  Correlates of psychologic distress in colorectal cancer patients undergoing genetic testing for hereditary colon cancer.

Authors:  S W Vernon; E R Gritz; S K Peterson; C I Amos; C A Perz; W F Baile; P M Lynch
Journal:  Health Psychol       Date:  1997-01       Impact factor: 4.267

View more
  15 in total

1.  Assessment of psychosocial outcomes in genetic counseling research: an overview of available measurement scales.

Authors:  Nadine A Kasparian; Claire E Wakefield; Bettina Meiser
Journal:  J Genet Couns       Date:  2007-08-13       Impact factor: 2.537

Review 2.  Evaluation of the methodological quality of systematic reviews of health status measurement instruments.

Authors:  Lidwine B Mokkink; Caroline B Terwee; Paul W Stratford; Jordi Alonso; Donald L Patrick; Ingrid Riphagen; Dirk L Knol; Lex M Bouter; Henrica C W de Vet
Journal:  Qual Life Res       Date:  2009-02-24       Impact factor: 4.147

3.  Development and validation of an instrument to measure the impact of genetic testing on self-concept in Lynch syndrome.

Authors:  M J Esplen; N Stuckless; S Gallinger; M Aronson; H Rothenmund; K Semotiuk; J Stokes; C Way; J Green; K Butler; H V Petersen; J Wong
Journal:  Clin Genet       Date:  2011-10-03       Impact factor: 4.438

4.  Validation of a self-concept scale for Lynch syndrome in different nationalities.

Authors:  Helle Vendel Petersen; Katarina Domanska; Pär-Ola Bendahl; Jiahui Wong; Christina Carlsson; Inge Bernstein; Mary Jane Esplen; Mef Nilbert
Journal:  J Genet Couns       Date:  2011-01-26       Impact factor: 2.537

5.  Genetic counseling for patients and families with hereditary breast and ovarian cancer in a developing Asian country: an observational descriptive study.

Authors:  Sook-Yee Yoon; Meow-Keong Thong; Nur Aishah Mohd Taib; Cheng-Har Yip; Soo-Hwang Teo
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

6.  A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer.

Authors:  Carolyn Y Fang; Carol Cherry; Karthik Devarajan; Tianyu Li; John Malick; Mary B Daly
Journal:  Gynecol Oncol       Date:  2009-01-13       Impact factor: 5.482

7.  Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers.

Authors:  Ashley D Staton; Allison W Kurian; Kristin Cobb; Meredith A Mills; James M Ford
Journal:  Fam Cancer       Date:  2007-11-17       Impact factor: 2.375

8.  Psychological and cancer-specific distress at 18 months post-testing in women with demonstrated BRCA1 mutations for hereditary breast/ovarian cancer.

Authors:  Jon G Reichelt; Pål Møller; Ketil Heimdal; Alv A Dahl
Journal:  Fam Cancer       Date:  2008-01-25       Impact factor: 2.375

9.  Intrusion and avoidance in subjects undergoing genetic investigation and counseling for hereditary cancer.

Authors:  Cathrine Bjorvatn; Geir Egil Eide; Berit R Hanestad; Anniken Hamang; Odd E Havik
Journal:  Support Care Cancer       Date:  2009-02-18       Impact factor: 3.603

10.  Testicular cancer and genetics knowledge among familial testicular cancer family members.

Authors:  June A Peters; Ellen B Beckjord; Deliya R Banda Ryan; Ann G Carr; Susan T Vadaparampil; Jennifer T Loud; Larissa Korde; Mark H Greene
Journal:  J Genet Couns       Date:  2008-05-15       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.